Propanc Biopharma PPCB Cash Flow Statement (2010-2025)

NASDAQ PPCB
$1.10 -0.04 (-3.51%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-0.42M-0.78M-0.49M-0.80M-0.46M-0.90M-0.62M-0.49M-0.81M-0.75M-0.35M-0.58M-0.53M-0.36M-0.35M-0.43M-54.07M-4.07M-4.84M-3.09M
Depreciation and Depletion (Quarter)
523.00526.00509.00504.00490.00490.00473.00422.00450.00320.00134.00114.0049.00125.00229.00
Share-based Compensation (Quarter)
0.02M0.06M0.13M0.02M0.02M-0.15M0.00M-46.73M3.02M
Gains from Investment Securities (Quarter)
-0.59M
Asset Writedowns and Impairment (Quarter)
0.00M0.00M0.00M0.00M160.00639.000.00M0.00M0.00M937.000.00M937.00
Cash from Operations (Quarter)
-0.47M-0.24M-0.49M-0.22M-0.31M-0.41M-0.51M-0.23M-0.19M-0.18M-0.33M-0.24M-0.10M-0.26M-0.24M0.02M-0.16M-0.03M-1.94M-1.00M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.00M0.01M-0.09M0.01M0.01M0.43M0.03M0.05M0.05M0.44M-0.09M0.08M0.08M0.56M0.06M0.08M0.01M-0.15M0.15M0.01M
Amortization of Deferred Charges (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.01M0.00M0.01M0.01M0.00M0.01M
Depreciation & Amortization (CF) (Quarter)
523.00526.00509.00504.00490.00490.00473.00422.00450.00320.00134.00114.0049.00125.00229.00
Change in Working Capital
Change in Receivables (Quarter)
0.00M295.00-0.00M0.00M-0.00M460.00523.000.00M-0.00M-455.00-132.000.00M0.00M-0.00M251.00-0.00M0.00M0.00M0.00M0.01M
Change in Account Payables (Quarter)
0.03M0.07M-0.14M0.09M0.02M0.05M0.05M-0.04M0.02M0.05M0.15M0.02M0.07M-58.00-0.02M0.12M0.02M0.07M-0.19M-0.12M
Change in Accured Expenses (Quarter)
-0.01M449.000.01M0.00M0.03M-0.01M0.01M0.02M0.20M-0.05M0.02M0.08M-0.06M0.01M0.02M0.03M0.29M-0.09M0.01M-0.37M
Other Working Capital Changes (Quarter)
-0.00M-0.01M-0.00M-0.01M-0.01M-0.01M-0.00M-0.01M-0.01M-0.00M-0.01M-0.01M0.00M-0.01M
Investing Activities
Capital Expenditures (Quarter)
0.00M0.00M
Cash from Investing Activities (Quarter)
-0.00M-0.00M
Financing Activities
Other financing activities (Quarter)
0.33M0.25M0.28M0.10M0.10M0.15M0.10M0.10M0.10M0.11M0.00M0.03M0.01M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
0.12M0.16M0.25M0.23M0.12M0.35M0.05M0.19M0.22M-0.05M0.02M0.00M0.06M0.01M0.02M0.02M0.10M-0.03M
Long-Term Debt Repayments (Quarter)
0.14M0.14M-0.14M0.14M0.20M
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
21.000.0639.0059.0059.000.0659.0059.0059.000.000.060.060.060.000.000.000.00
Net Equity Issued and Repurchased (Quarter)
0.10M0.02M0.23M0.09M0.20M0.01M3.31M
Misc.
Cash from Financing Activities (Quarter)
0.45M0.25M0.43M0.35M0.33M0.37M0.49M0.25M0.27M0.10M0.35M0.27M0.07M0.25M0.22M0.05M0.21M0.01M2.53M0.97M
Exchange Rate Effect (Quarter)
0.01M-0.03M0.10M-0.10M0.05M-0.09M0.03M-0.02M-0.01M-0.01M-0.02M0.03M-0.03M0.02M0.01M-0.07M-0.02M-0.02M0.01M-0.01M
Change in Cash (Quarter)
-0.01M-0.01M0.04M0.03M0.06M-0.13M0.02M0.01M0.07M-0.08M-0.00M0.07M-0.07M0.01M-0.01M0.01M0.04M-0.04M0.59M-0.04M
Free Cash Flow (Quarter)
-0.47M-0.24M-0.49M-0.22M-0.31M-0.41M-0.51M-0.23M-0.19M-0.18M-0.33M-0.24M-0.10M-0.26M-0.24M0.02M-0.16M-0.03M-1.94M-1.00M
Net Cash Flow (Quarter)
-0.02M0.01M-0.05M0.13M0.01M-0.04M-0.02M0.02M0.08M-0.08M0.02M0.04M-0.04M-0.01M-0.02M0.07M0.05M-0.02M0.59M-0.04M